Sun Pharma gets USFDA nod for ILUMYA to treat psoriatic arthritis
Sun Pharmaceutical Industries on Friday, 30 October 2026, said the US Food and Drug Administration had approved its drug ILUMYA (tildrakizumab-asmn) for treating adults with active psoriatic arthritis. The approval expands the…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.